These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


374 related items for PubMed ID: 31158803

  • 1. Heamatococcus pluvialis ameliorates bone loss in experimentally-induced osteoporosis in rats via the regulation of OPG/RANKL pathway.
    El-Baz FK, Saleh DO, Abdel Jaleel GA, Hussein RA, Hassan A.
    Biomed Pharmacother; 2019 Aug; 116():109017. PubMed ID: 31158803
    [Abstract] [Full Text] [Related]

  • 2. Effect of Zuoguiwan on osteoporosis in ovariectomized rats through RANKL/OPG pathway mediated by β2AR.
    Liu F, Tan F, Tong W, Fan Q, Ye S, Lu S, Teng Z, Han M, Zhang M, Chai Y.
    Biomed Pharmacother; 2018 Jul; 103():1052-1060. PubMed ID: 29710663
    [Abstract] [Full Text] [Related]

  • 3. [Electroacupuncture Intervention Improves Cartilage Degeneration and Subchondral Bone Osteoporosis of Knee-joint Possibly by Adjusting OPG/RANK/RANKL Signaling in Ovariectomized Rats].
    Sun GH, Liao Y, Liao Y, Ni ZY, Li N, Zhong PR, Li XH, Zhou J.
    Zhen Ci Yan Jiu; 2018 Dec 25; 43(12):781-7. PubMed ID: 30585456
    [Abstract] [Full Text] [Related]

  • 4. Oral Exposure to ZnO Nanoparticles Disrupt the Structure of Bone in Young Rats via the OPG/RANK/RANKL/IGF-1 Pathway.
    Xu X, Tang Y, Lang Y, Liu Y, Cheng W, Xu H, Liu Y.
    Int J Nanomedicine; 2020 Dec 25; 15():9657-9668. PubMed ID: 33299310
    [Abstract] [Full Text] [Related]

  • 5. Bovine lactoferrin improves bone mass and microstructure in ovariectomized rats via OPG/RANKL/RANK pathway.
    Hou JM, Xue Y, Lin QM.
    Acta Pharmacol Sin; 2012 Oct 25; 33(10):1277-84. PubMed ID: 22902986
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the effects of genistein and zoledronic acid on the bone loss in OPG-deficient mice.
    Liu J, Xu K, Wen G, Guo H, Li S, Wu X, Dai R, Sheng Z, Liao E.
    Bone; 2008 May 25; 42(5):950-9. PubMed ID: 18337202
    [Abstract] [Full Text] [Related]

  • 7. Tetrandrine Attenuates Cartilage Degeneration, Osteoclast Proliferation, and Macrophage Transformation through Inhibiting P65 Phosphorylation in Ovariectomy-induced Osteoporosis.
    Shi F, Ni L, Gao YM.
    Immunol Invest; 2022 Apr 25; 51(3):465-479. PubMed ID: 33140671
    [Abstract] [Full Text] [Related]

  • 8. Increased RANK ligand in bone marrow of orchiectomized rats and prevention of their bone loss by the RANK ligand inhibitor osteoprotegerin.
    Li X, Ominsky MS, Stolina M, Warmington KS, Geng Z, Niu QT, Asuncion FJ, Tan HL, Grisanti M, Dwyer D, Adamu S, Ke HZ, Simonet WS, Kostenuik PJ.
    Bone; 2009 Oct 25; 45(4):669-76. PubMed ID: 19539794
    [Abstract] [Full Text] [Related]

  • 9. Berberine alleviates oxidative stress in rats with osteoporosis through receptor activator of NF-kB/receptor activator of NF-kB ligand/osteoprotegerin (RANK/RANKL/OPG) pathway.
    He XF, Zhang L, Zhang CH, Zhao CR, Li H, Zhang LF, Tian GF, Guo MF, Dai Z, Sui FG.
    Bosn J Basic Med Sci; 2017 Nov 20; 17(4):295-301. PubMed ID: 29055350
    [Abstract] [Full Text] [Related]

  • 10. Up-regulated CST5 inhibits bone resorption and activation of osteoclasts in rat models of osteoporosis via suppression of the NF-κB pathway.
    Wang F, Zhang C, Ge W, Zhang G.
    J Cell Mol Med; 2019 Oct 20; 23(10):6744-6754. PubMed ID: 31402549
    [Abstract] [Full Text] [Related]

  • 11. Genistein and Silicon Synergistically Protects Against Ovariectomy-Induced Bone Loss Through Upregulating OPG/RANKL Ratio.
    Chen C, Zheng H, Qi S.
    Biol Trace Elem Res; 2019 Apr 20; 188(2):441-450. PubMed ID: 30014283
    [Abstract] [Full Text] [Related]

  • 12. Strontium fructose 1,6-diphosphate prevents bone loss in a rat model of postmenopausal osteoporosis via the OPG/RANKL/RANK pathway.
    Ma B, Zhang Q, Wu D, Wang YL, Hu YY, Cheng YP, Yang ZD, Zheng YY, Ying HJ.
    Acta Pharmacol Sin; 2012 Apr 20; 33(4):479-89. PubMed ID: 22426695
    [Abstract] [Full Text] [Related]

  • 13. Osteoblast-Specific Overexpression of Human WNT16 Increases Both Cortical and Trabecular Bone Mass and Structure in Mice.
    Alam I, Alkhouli M, Gerard-O'Riley RL, Wright WB, Acton D, Gray AK, Patel B, Reilly AM, Lim KE, Robling AG, Econs MJ.
    Endocrinology; 2016 Feb 20; 157(2):722-36. PubMed ID: 26584014
    [Abstract] [Full Text] [Related]

  • 14. Overloaded Orthopedic Force Induces Condylar Subchondral Bone Absorption by Stimulating Rat Mesenchymal Stem Cells Differentiating into Osteoclasts via mTOR-Regulated RANKL/OPG Secretion in Osteoblasts.
    Tian Y, Chen J, Yan X, Ren D, Liu M, Zhang Q, Zhang Q, Yuan X.
    Stem Cells Dev; 2021 Jan 01; 30(1):29-38. PubMed ID: 33176606
    [Abstract] [Full Text] [Related]

  • 15. Zoledronate reverses mandibular bone loss in osteoprotegerin-deficient mice.
    Sheng ZF, Xu K, Ma YL, Liu JH, Dai RC, Zhang YH, Jiang YB, Liao EY.
    Osteoporos Int; 2009 Jan 01; 20(1):151-9. PubMed ID: 18496637
    [Abstract] [Full Text] [Related]

  • 16. Thrombin receptor deficiency leads to a high bone mass phenotype by decreasing the RANKL/OPG ratio.
    Tudpor K, van der Eerden BC, Jongwattanapisan P, Roelofs JJ, van Leeuwen JP, Bindels RJ, Hoenderop JG.
    Bone; 2015 Mar 01; 72():14-22. PubMed ID: 25460576
    [Abstract] [Full Text] [Related]

  • 17. Protective effect of resveratrol on estrogen deficiency-induced osteoporosis though attenuating NADPH oxidase 4/nuclear factor kappa B pathway by increasing miR-92b-3p expression.
    Zhang Y, Liu MW, He Y, Deng N, Chen Y, Huang J, Xie W.
    Int J Immunopathol Pharmacol; 2020 Mar 01; 34():2058738420941762. PubMed ID: 32674689
    [Abstract] [Full Text] [Related]

  • 18. Baicalin Ameliorates Dexamethasone-Induced Osteoporosis by Regulation of the RANK/RANKL/OPG Signaling Pathway.
    Zhao Y, Wang HL, Li TT, Yang F, Tzeng CM.
    Drug Des Devel Ther; 2020 Mar 01; 14():195-206. PubMed ID: 32021104
    [Abstract] [Full Text] [Related]

  • 19. Higher levels of s-RANKL and osteoprotegerin in children and adolescents with type 1 diabetes mellitus may indicate increased osteoclast signaling and predisposition to lower bone mass: a multivariate cross-sectional analysis.
    Tsentidis C, Gourgiotis D, Kossiva L, Doulgeraki A, Marmarinos A, Galli-Tsinopoulou A, Karavanaki K.
    Osteoporos Int; 2016 Apr 01; 27(4):1631-1643. PubMed ID: 26588909
    [Abstract] [Full Text] [Related]

  • 20. Estrogen Deficiency-Associated Bone Loss in the Maxilla: A Methodology to Quantify the Changes in the Maxillary Intra-radicular Alveolar Bone in an Ovariectomized Rat Osteoporosis Model.
    Du Z, Steck R, Doan N, Woodruff MA, Ivanovski S, Xiao Y.
    Tissue Eng Part C Methods; 2015 May 01; 21(5):458-66. PubMed ID: 25315176
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.